ANTI-LIPOLYTIC STRATEGY FOR HIV LIPODYSTROPHY

HIV 脂肪营养不良的抗脂肪分解策略

• 批准号: 7607106
• 负责人: COLLEEN M HADIGAN
• 金额: $ 1.69万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607106
• 关键词: Chronic; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; HIV Infections; Hypertriglyceridemia; Institution; Lipodystrophy; Patients; Purpose; Research; Research Personnel; Resources; Source; United States National Institutes of Health; acipimox

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine the utility of chronic administration of acipimox for the treatment of hypertriglyceridemia in patients with HIV infection and lipodystrophy.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的目的是确定长期给予阿昔莫司治疗HIV感染和脂肪代谢障碍患者的高脂血症的效用。